Projects per year
Search results
-
Active
Development of ALS gene therapies for targeted protein degradation of TDP-43
Lee, A., Morsch, M., Rayner, S. & Chung, R.
1/09/24 → 31/08/26
Project: Research
-
IDEAS 23: TDP-43 nuclear depletion in MND - potential driver of neurodegeneration and therapeutic target
Hogan, A., Maurel, C., Rayner, S., Morsch, M., Williams, K., Walker, A. K. & Lisowski, L.
1/07/24 → 30/06/27
Project: Research
-
FightMND ECRF: Improving the likelihood of translation of novel degrader technology for the treatment of MND
Rayner, S., Lee, A., Chung, R., Halliday, G., Walker, A. K. & Liu, F.
1/10/23 → 30/09/27
Project: Research
-
FightMND Discovery: Deciphering the role of TDP43 regulation of cryptic exons in ALS pathogenesis
Chung, R., Williams, K., Lee, A., Morsch, M., Rayner, S. & Grima, N.
1/10/23 → 30/09/26
Project: Research
-
Finished
Development of a TDP43-targeting gene therapy for ALS
Chung, R., Lisowski, L., Walker, A. K., Rogers, M., Lee, A., Morsch, M. & Rayner, S.
1/10/20 → 30/09/23
Project: Research
-
Clearance of TDP-43 by PROteolysis TArgeting Chimera (PROTAC) dual targeting to treat amyotrophic lateral sclerosis (ALS)
Lee, A., Rayner, S., Martin, A., van Hummel, A., Morsch, M., Shi, B., Ke, Y., Ittner, L. & Chung, R.
4/05/20 → 3/05/21
Project: Research
-
Refinement of CCNF gene therapy for MND
Rayner, S., Lee, A. & Chung, R.
1/08/19 → 30/06/20
Project: Research
-
Revealing the role of protein clearance pathways in sporadic ALS
Chung, R., Lee, A., Rayner, S. & Yang, S.
1/05/19 → 30/04/20
Project: Research
-
Pre-clinical evaluation of novel therapies for clearance of TDP-43 in amyotrophic lateral sclerosis
Chung, R., Walker, A. K., Ittner, L., Lee, A. & Rayner, S.
1/01/19 → 31/12/19
Project: Research